logo
  

AstraZeneca Slips To Loss In Q3, Revenues Climb; Backs FY21 Outlook - Quick Facts

British drug major AstraZeneca (AZN.L,AZN) reported Friday a loss before tax in its third quarter of $2 billion, compared to last year's profit of $853 million. Loss per share was $1.10, compared to profit of $0.49 a year ago.

Core earnings per share were $1.08. The company noted that the impact of pandemic vaccine on earnings per share was $0.01.

EBITDA declined 6 percent to $5.69 billion.

Total revenue in the third quarter increased 50 percent to $9.87 billion from last year's $6.58 billion. The revenues grew 48 percent at constant exchange rates.

Excluding the pandemic COVID-19 vaccine, total revenue increased 34 percent on a reported basis and 32 percent at CER in the quarter to $8.82 billion.

Looking ahead, the company said its earnings guidance for the full year 2021 remains unchanged. The company continues to project growth in Core earnings per share to $5.05 to $5.40.

Total revenue excluding the COVID-19 vaccine is expected to grow by a low-twenties percentage, in line with prior guidance. Including vaccine revenues in Q4 2021, revenue is expected to grow by a mid-to-high twenties percentage.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA has urged infant formula manufacturers to import infant formula products to the United States to meet the ongoing severe supply shortage. In order to further increase the availability of infant formula in the country, while protecting the health of infants, the regulator announced a guidance outlining increased flexibilities for the global manufacturers Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2023 that declined 24.8 percent from last year, hurt by lower gross margins and net losses on equity investments. Adjusted earnings per share also missed analysts' expectations, but quarterly revenues topped it. The retailer also cut its earnings guidance for the second quarter and for the full-year 2023. Billionaire and Tesla CEO Elon Musk, who is in deal to acquire Twitter Inc., may seek a lower price for the social media platform as he estimates that there could be at least four times more fake accounts than what the company informed, Reuters reported. It was in late April that Twitter agreed to accept Musk's about $44 billion takeover offer and to become a privately held company.
Follow RTT